DA-5223-R
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-5223-R, covering 2025-08-19 to 2025-08-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects [Phase 1]